

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 7.57518668 |
| 2 | proline metabolic process (GO:0006560) | 5.86953604 |
| 3 | embryonic process involved in female pregnancy (GO:0060136) | 5.61727508 |
| 4 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 5.11798606 |
| 5 | regulation of translational fidelity (GO:0006450) | 5.06636703 |
| 6 | regulation of integrin activation (GO:0033623) | 5.04154886 |
| 7 | transcription from mitochondrial promoter (GO:0006390) | 4.95472261 |
| 8 | establishment of apical/basal cell polarity (GO:0035089) | 4.77795316 |
| 9 | positive regulation of protein homooligomerization (GO:0032464) | 4.35576587 |
| 10 | mitotic G1 DNA damage checkpoint (GO:0031571) | 4.34231029 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 4.24063822 |
| 12 | mitochondrial DNA metabolic process (GO:0032042) | 4.18171485 |
| 13 | regulation of protein homooligomerization (GO:0032462) | 4.14539079 |
| 14 | embryonic placenta development (GO:0001892) | 3.99570270 |
| 15 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.99040412 |
| 16 | establishment of monopolar cell polarity (GO:0061162) | 3.99040412 |
| 17 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.98221537 |
| 18 | cell-substrate adherens junction assembly (GO:0007045) | 3.96931261 |
| 19 | focal adhesion assembly (GO:0048041) | 3.96931261 |
| 20 | mitotic G1/S transition checkpoint (GO:0044819) | 3.96551480 |
| 21 | mannose metabolic process (GO:0006013) | 3.96236721 |
| 22 | Golgi transport vesicle coating (GO:0048200) | 3.94241668 |
| 23 | COPI coating of Golgi vesicle (GO:0048205) | 3.94241668 |
| 24 | adherens junction assembly (GO:0034333) | 3.90100434 |
| 25 | oxidative demethylation (GO:0070989) | 3.82375618 |
| 26 | protein localization to endosome (GO:0036010) | 3.80014145 |
| 27 | replication fork processing (GO:0031297) | 3.78850410 |
| 28 | G1 DNA damage checkpoint (GO:0044783) | 3.78232020 |
| 29 | cell-substrate junction assembly (GO:0007044) | 3.75034856 |
| 30 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.70791953 |
| 31 | regulation of cholesterol homeostasis (GO:2000188) | 3.69936213 |
| 32 | apoptotic process involved in morphogenesis (GO:0060561) | 3.55505256 |
| 33 | negative regulation of cell size (GO:0045792) | 3.48981344 |
| 34 | regulation of RNA export from nucleus (GO:0046831) | 3.47513583 |
| 35 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.45179554 |
| 36 | mRNA cleavage (GO:0006379) | 3.43105061 |
| 37 | negative regulation of fatty acid transport (GO:2000192) | 3.41161025 |
| 38 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.34490890 |
| 39 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.34490890 |
| 40 | basement membrane organization (GO:0071711) | 3.29783940 |
| 41 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.29782581 |
| 42 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.27517450 |
| 43 | regulation of hippo signaling (GO:0035330) | 3.26087197 |
| 44 | heterochromatin organization (GO:0070828) | 3.23480802 |
| 45 | positive regulation of protein oligomerization (GO:0032461) | 3.22470133 |
| 46 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.21816541 |
| 47 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.19815310 |
| 48 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.19815310 |
| 49 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.19815310 |
| 50 | dosage compensation (GO:0007549) | 3.16854544 |
| 51 | pinocytosis (GO:0006907) | 3.15673168 |
| 52 | trophectodermal cell differentiation (GO:0001829) | 3.13270791 |
| 53 | regulation of sister chromatid cohesion (GO:0007063) | 3.09787701 |
| 54 | labyrinthine layer development (GO:0060711) | 3.07875940 |
| 55 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.07758283 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05306214 |
| 57 | regulation of histone H3-K27 methylation (GO:0061085) | 3.05102434 |
| 58 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05045227 |
| 59 | glyoxylate metabolic process (GO:0046487) | 3.03884954 |
| 60 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.02309542 |
| 61 | nuclear pore complex assembly (GO:0051292) | 2.98941664 |
| 62 | hemidesmosome assembly (GO:0031581) | 2.98799951 |
| 63 | 4-hydroxyproline metabolic process (GO:0019471) | 2.98206577 |
| 64 | intestinal cholesterol absorption (GO:0030299) | 2.97373635 |
| 65 | negative regulation of viral release from host cell (GO:1902187) | 2.96432185 |
| 66 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.94662019 |
| 67 | alkaloid metabolic process (GO:0009820) | 2.93930588 |
| 68 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.93526565 |
| 69 | regulation of gene silencing by miRNA (GO:0060964) | 2.93526565 |
| 70 | regulation of gene silencing by RNA (GO:0060966) | 2.93526565 |
| 71 | anatomical structure regression (GO:0060033) | 2.93469692 |
| 72 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.92258751 |
| 73 | positive regulation of histone deacetylation (GO:0031065) | 2.91983223 |
| 74 | semaphorin-plexin signaling pathway (GO:0071526) | 2.91862861 |
| 75 | low-density lipoprotein particle clearance (GO:0034383) | 2.90524075 |
| 76 | mitotic chromosome condensation (GO:0007076) | 2.89996521 |
| 77 | alpha-linolenic acid metabolic process (GO:0036109) | 2.89444554 |
| 78 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.88170568 |
| 79 | cellular response to ATP (GO:0071318) | 2.87479143 |
| 80 | maternal placenta development (GO:0001893) | 2.86635084 |
| 81 | embryonic camera-type eye development (GO:0031076) | 2.86362252 |
| 82 | regulation of protein polyubiquitination (GO:1902914) | 2.85985382 |
| 83 | positive regulation of receptor recycling (GO:0001921) | 2.85298847 |
| 84 | negative regulation of cell cycle arrest (GO:0071157) | 2.84314149 |
| 85 | regulation of protein oligomerization (GO:0032459) | 2.84293634 |
| 86 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.83443034 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 2.82749820 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82749820 |
| 89 | formation of translation preinitiation complex (GO:0001731) | 2.82036634 |
| 90 | triglyceride homeostasis (GO:0070328) | 2.80990404 |
| 91 | acylglycerol homeostasis (GO:0055090) | 2.80990404 |
| 92 | acetyl-CoA metabolic process (GO:0006084) | 2.80616473 |
| 93 | stress fiber assembly (GO:0043149) | 2.80380526 |
| 94 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.79127537 |
| 95 | fatty acid transmembrane transport (GO:1902001) | 2.78736649 |
| 96 | serine family amino acid catabolic process (GO:0009071) | 2.78592420 |
| 97 | pre-miRNA processing (GO:0031054) | 2.78317366 |
| 98 | carnitine shuttle (GO:0006853) | 2.77981157 |
| 99 | regulation of podosome assembly (GO:0071801) | 2.77639955 |
| 100 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.77468788 |
| 101 | negative regulation of protein oligomerization (GO:0032460) | 2.77325088 |
| 102 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76409269 |
| 103 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.74777136 |
| 104 | regulation of translational elongation (GO:0006448) | 2.74727713 |
| 105 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.74515420 |
| 106 | epithelial cell-cell adhesion (GO:0090136) | 2.74256018 |
| 107 | negative regulation of Ras GTPase activity (GO:0034261) | 2.72649372 |
| 108 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72031988 |
| 109 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.70673636 |
| 110 | heme transport (GO:0015886) | 2.70015912 |
| 111 | desmosome organization (GO:0002934) | 2.68218157 |
| 112 | positive regulation of chromosome segregation (GO:0051984) | 2.68125454 |
| 113 | regulation of cell size (GO:0008361) | 2.67814313 |
| 114 | regulation of necroptotic process (GO:0060544) | 2.67058207 |
| 115 | cysteine metabolic process (GO:0006534) | 2.66913626 |
| 116 | cytolysis (GO:0019835) | 2.66027905 |
| 117 | snRNA metabolic process (GO:0016073) | 2.65796499 |
| 118 | anterior/posterior axis specification, embryo (GO:0008595) | 2.65602088 |
| 119 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.64865447 |
| 120 | glycine metabolic process (GO:0006544) | 2.64702069 |
| 121 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.64153368 |
| 122 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62930831 |
| 123 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.61723237 |
| 124 | cellular response to virus (GO:0098586) | 2.61621301 |
| 125 | modulation by symbiont of host cellular process (GO:0044068) | 2.61404917 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61271642 |
| 127 | negative regulation of fibrinolysis (GO:0051918) | 2.60964587 |
| 128 | regulation of early endosome to late endosome transport (GO:2000641) | 2.60589185 |
| 129 | base-excision repair (GO:0006284) | 2.58317989 |
| 130 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.56546649 |
| 131 | convergent extension (GO:0060026) | 2.54921392 |
| 132 | skin morphogenesis (GO:0043589) | 2.54329803 |
| 133 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.54070025 |
| 134 | striated muscle atrophy (GO:0014891) | 2.53688186 |
| 135 | receptor catabolic process (GO:0032801) | 2.53552041 |
| 136 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.52961560 |
| 137 | barbed-end actin filament capping (GO:0051016) | 2.50853139 |
| 138 | skeletal muscle adaptation (GO:0043501) | 2.50220609 |
| 139 | positive regulation of nuclease activity (GO:0032075) | 2.49587824 |
| 140 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.48749146 |
| 141 | DNA strand renaturation (GO:0000733) | 2.48369400 |
| 142 | plasma lipoprotein particle assembly (GO:0034377) | 2.46546709 |
| 143 | negative regulation of necroptotic process (GO:0060546) | 2.46111598 |
| 144 | activation of Rac GTPase activity (GO:0032863) | 2.45939293 |
| 145 | corticosteroid receptor signaling pathway (GO:0031958) | 2.45574029 |
| 146 | positive regulation by host of viral transcription (GO:0043923) | 2.44225626 |
| 147 | negative regulation of myotube differentiation (GO:0010832) | 2.43597777 |
| 148 | protein-lipid complex assembly (GO:0065005) | 2.43228514 |
| 149 | urea cycle (GO:0000050) | 2.42637834 |
| 150 | urea metabolic process (GO:0019627) | 2.42637834 |
| 151 | lysine metabolic process (GO:0006553) | 2.42208352 |
| 152 | lysine catabolic process (GO:0006554) | 2.42208352 |
| 153 | serine family amino acid metabolic process (GO:0009069) | 2.41643122 |
| 154 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.38921658 |
| 155 | regulation of translational termination (GO:0006449) | 2.38523936 |
| 156 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.38410901 |
| 157 | peptidyl-lysine dimethylation (GO:0018027) | 2.37555719 |
| 158 | positive regulation of protein deacetylation (GO:0090312) | 2.36906964 |
| 159 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.36405874 |
| 160 | positive regulation of protein dephosphorylation (GO:0035307) | 2.34246085 |
| 161 | membrane protein ectodomain proteolysis (GO:0006509) | 2.32836684 |
| 162 | NIK/NF-kappaB signaling (GO:0038061) | 2.32372955 |
| 163 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.31424243 |
| 164 | positive regulation of myotube differentiation (GO:0010831) | 2.30163499 |
| 165 | ER-nucleus signaling pathway (GO:0006984) | 2.29123841 |
| 166 | cell adhesion mediated by integrin (GO:0033627) | 2.28864647 |
| 167 | snRNA processing (GO:0016180) | 2.28111785 |
| 168 | protein hydroxylation (GO:0018126) | 2.27955813 |
| 169 | response to laminar fluid shear stress (GO:0034616) | 2.27785320 |
| 170 | protein retention in ER lumen (GO:0006621) | 2.27106057 |
| 171 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.26906529 |
| 172 | nuclear pore organization (GO:0006999) | 2.24617850 |
| 173 | pore complex assembly (GO:0046931) | 2.22344237 |
| 174 | regulation of nuclease activity (GO:0032069) | 2.21603972 |
| 175 | hypotonic response (GO:0006971) | 2.19665753 |
| 176 | histone H3-K36 demethylation (GO:0070544) | 2.19241471 |
| 177 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.18831110 |
| 178 | cellular response to unfolded protein (GO:0034620) | 2.18437920 |
| 179 | regulation of chromatin binding (GO:0035561) | 2.17886170 |
| 180 | activation of MAPKKK activity (GO:0000185) | 2.16643400 |
| 181 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.16129368 |
| 182 | pentose-phosphate shunt (GO:0006098) | 2.15626165 |
| 183 | modulation by virus of host process (GO:0019054) | 2.15492672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.03924066 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85118761 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.64440288 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.57505021 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54628775 |
| 6 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.43663716 |
| 7 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.36436504 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.34338617 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.25899839 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20252766 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18341386 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.14536722 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.12276440 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.04031370 |
| 15 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.00009209 |
| 16 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.99280541 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.96390943 |
| 18 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.96390943 |
| 19 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.96390943 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.96249805 |
| 21 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.91716626 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88343788 |
| 23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86981272 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85513296 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82058902 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80757918 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.78900127 |
| 28 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.78245384 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77982895 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.76802094 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72672476 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68619780 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.64451479 |
| 34 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.64198759 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.61593724 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60719978 |
| 37 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.58519712 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56970771 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56331358 |
| 40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54996861 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.54949333 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53735932 |
| 43 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.53452248 |
| 44 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.52272957 |
| 45 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.52143726 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.51602522 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49626960 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48304540 |
| 49 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.47772757 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46624794 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45824660 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45431669 |
| 53 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44632137 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.44041761 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43863267 |
| 56 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.42375612 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42046679 |
| 58 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41959649 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41340845 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39697029 |
| 61 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.39629413 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.37802484 |
| 63 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.37261905 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.36592523 |
| 65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35581038 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.35246457 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33778798 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33619875 |
| 69 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.32981658 |
| 70 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31413910 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26499941 |
| 72 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.25609770 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25209090 |
| 74 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.24773528 |
| 75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24469431 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24056037 |
| 77 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.24038377 |
| 78 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.23246821 |
| 79 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.23083278 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23039818 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.21635684 |
| 82 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20232350 |
| 83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20228975 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19744848 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.19488661 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19412172 |
| 87 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19111675 |
| 88 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18311379 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16734000 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15989530 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14645107 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14578659 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14181857 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13818883 |
| 95 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13714540 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13670040 |
| 97 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11977357 |
| 98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11426541 |
| 99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11213492 |
| 100 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10953142 |
| 101 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.10602427 |
| 102 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10422086 |
| 103 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09850164 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09652551 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09455122 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08545212 |
| 107 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08332923 |
| 108 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08143406 |
| 109 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.06892083 |
| 110 | MAF_26560356_Chip-Seq_TH1_Human | 1.06567476 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06270455 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06270455 |
| 113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05301812 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05049433 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04968501 |
| 116 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04465049 |
| 117 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04248479 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03847040 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03847040 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03610368 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03486430 |
| 122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02961536 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02616973 |
| 124 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02324039 |
| 125 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02105290 |
| 126 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.01752388 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01629847 |
| 128 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01442552 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01300635 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01263473 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00989223 |
| 132 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00712904 |
| 133 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.00335120 |
| 134 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.98758944 |
| 135 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.98543118 |
| 136 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98371274 |
| 137 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98321112 |
| 138 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98178668 |
| 139 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98098056 |
| 140 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97712141 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97186693 |
| 142 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96977308 |
| 143 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96730687 |
| 144 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96551842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.66856048 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.45792528 |
| 3 | MP0009278_abnormal_bone_marrow | 3.19894451 |
| 4 | MP0008057_abnormal_DNA_replication | 3.02643393 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 2.93841227 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.92035443 |
| 7 | MP0005365_abnormal_bile_salt | 2.73065100 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.71403740 |
| 9 | MP0004233_abnormal_muscle_weight | 2.57714582 |
| 10 | MP0005360_urolithiasis | 2.47886705 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.43722871 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.33778968 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.19592617 |
| 14 | MP0003091_abnormal_cell_migration | 1.88761750 |
| 15 | MP0005409_darkened_coat_color | 1.85843913 |
| 16 | MP0001348_abnormal_lacrimal_gland | 1.81587198 |
| 17 | MP0009840_abnormal_foam_cell | 1.77656329 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 1.75999536 |
| 19 | MP0002269_muscular_atrophy | 1.75013835 |
| 20 | MP0005257_abnormal_intraocular_pressure | 1.74576376 |
| 21 | MP0003453_abnormal_keratinocyte_physiol | 1.69621762 |
| 22 | MP0000003_abnormal_adipose_tissue | 1.68911808 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.68623583 |
| 24 | MP0004197_abnormal_fetal_growth/weight/ | 1.64730549 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 1.59618678 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.57315564 |
| 27 | MP0002086_abnormal_extraembryonic_tissu | 1.56771652 |
| 28 | MP0005171_absent_coat_pigmentation | 1.55625445 |
| 29 | MP0004858_abnormal_nervous_system | 1.51521307 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.45488366 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.45302635 |
| 32 | MP0010307_abnormal_tumor_latency | 1.45154255 |
| 33 | MP0003303_peritoneal_inflammation | 1.44886476 |
| 34 | MP0008260_abnormal_autophagy | 1.43162786 |
| 35 | MP0003283_abnormal_digestive_organ | 1.42415086 |
| 36 | MP0001730_embryonic_growth_arrest | 1.40982774 |
| 37 | MP0005083_abnormal_biliary_tract | 1.39847809 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.39481025 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.39481025 |
| 40 | MP0002796_impaired_skin_barrier | 1.38900446 |
| 41 | MP0002084_abnormal_developmental_patter | 1.38341419 |
| 42 | MP0001697_abnormal_embryo_size | 1.38170567 |
| 43 | MP0003252_abnormal_bile_duct | 1.38151932 |
| 44 | MP0004272_abnormal_basement_membrane | 1.36605294 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.35217677 |
| 46 | MP0009053_abnormal_anal_canal | 1.34197453 |
| 47 | MP0004947_skin_inflammation | 1.34113821 |
| 48 | MP0005380_embryogenesis_phenotype | 1.33724471 |
| 49 | MP0001672_abnormal_embryogenesis/_devel | 1.33724471 |
| 50 | MP0003119_abnormal_digestive_system | 1.30527593 |
| 51 | MP0001661_extended_life_span | 1.29807339 |
| 52 | MP0004957_abnormal_blastocyst_morpholog | 1.29385148 |
| 53 | MP0000609_abnormal_liver_physiology | 1.26641581 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.24231310 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.22422569 |
| 56 | MP0008995_early_reproductive_senescence | 1.21754316 |
| 57 | MP0010630_abnormal_cardiac_muscle | 1.20427936 |
| 58 | MP0010329_abnormal_lipoprotein_level | 1.19300670 |
| 59 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19028058 |
| 60 | MP0003984_embryonic_growth_retardation | 1.19000117 |
| 61 | MP0003279_aneurysm | 1.18608664 |
| 62 | MP0000858_altered_metastatic_potential | 1.18416156 |
| 63 | MP0002009_preneoplasia | 1.18265452 |
| 64 | MP0002085_abnormal_embryonic_tissue | 1.17802220 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 1.17589279 |
| 66 | MP0005023_abnormal_wound_healing | 1.16962403 |
| 67 | MP0004130_abnormal_muscle_cell | 1.15862535 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.14618963 |
| 69 | MP0000579_abnormal_nail_morphology | 1.13540553 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.13007585 |
| 71 | MP0002089_abnormal_postnatal_growth/wei | 1.11929201 |
| 72 | MP0000371_diluted_coat_color | 1.11422677 |
| 73 | MP0002282_abnormal_trachea_morphology | 1.10265358 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.10004265 |
| 75 | MP0003111_abnormal_nucleus_morphology | 1.09001581 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.07222166 |
| 77 | MP0002060_abnormal_skin_morphology | 1.06873381 |
| 78 | MP0006138_congestive_heart_failure | 1.06461138 |
| 79 | MP0005621_abnormal_cell_physiology | 1.06062757 |
| 80 | MP0005330_cardiomyopathy | 1.05932581 |
| 81 | MP0009115_abnormal_fat_cell | 1.05291981 |
| 82 | MP0004381_abnormal_hair_follicle | 1.05146779 |
| 83 | MP0000350_abnormal_cell_proliferation | 1.04808088 |
| 84 | MP0003763_abnormal_thymus_physiology | 1.04339889 |
| 85 | MP0005623_abnormal_meninges_morphology | 1.03058355 |
| 86 | MP0003436_decreased_susceptibility_to | 1.01288471 |
| 87 | MP0000767_abnormal_smooth_muscle | 1.00445697 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 1.00372699 |
| 89 | MP0002080_prenatal_lethality | 1.00192362 |
| 90 | MP0000733_abnormal_muscle_development | 0.99991173 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.98637541 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.96431860 |
| 93 | MP0000747_muscle_weakness | 0.95384809 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 0.95242577 |
| 95 | MP0003045_fibrosis | 0.95216943 |
| 96 | MP0001873_stomach_inflammation | 0.94630310 |
| 97 | MP0004510_myositis | 0.94168373 |
| 98 | MP0000598_abnormal_liver_morphology | 0.93610494 |
| 99 | MP0008438_abnormal_cutaneous_collagen | 0.93048140 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92095247 |
| 101 | MP0000749_muscle_degeneration | 0.91811028 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.91679717 |
| 103 | MP0001293_anophthalmia | 0.89857611 |
| 104 | MP0001849_ear_inflammation | 0.89377275 |
| 105 | MP0002971_abnormal_brown_adipose | 0.88683593 |
| 106 | MP0000685_abnormal_immune_system | 0.88135226 |
| 107 | MP0001958_emphysema | 0.88119105 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.87546574 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.87171496 |
| 110 | MP0002118_abnormal_lipid_homeostasis | 0.87014521 |
| 111 | MP0002075_abnormal_coat/hair_pigmentati | 0.86715977 |
| 112 | MP0001915_intracranial_hemorrhage | 0.86578655 |
| 113 | MP0002111_abnormal_tail_morphology | 0.86148843 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.86026213 |
| 115 | MP0000750_abnormal_muscle_regeneration | 0.85964887 |
| 116 | MP0002970_abnormal_white_adipose | 0.85881289 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.85615005 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.85461532 |
| 119 | MP0003646_muscle_fatigue | 0.85411201 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.84926854 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.84515638 |
| 122 | MP0005332_abnormal_amino_acid | 0.83279422 |
| 123 | MP0004036_abnormal_muscle_relaxation | 0.83168492 |
| 124 | MP0005501_abnormal_skin_physiology | 0.82705460 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.82315869 |
| 126 | MP0001340_abnormal_eyelid_morphology | 0.82202809 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.81908008 |
| 128 | MP0009931_abnormal_skin_appearance | 0.80350973 |
| 129 | MP0003786_premature_aging | 0.80204120 |
| 130 | MP0005266_abnormal_metabolism | 0.79629930 |
| 131 | MP0003828_pulmonary_edema | 0.78819583 |
| 132 | MP0008877_abnormal_DNA_methylation | 0.78462857 |
| 133 | MP0003077_abnormal_cell_cycle | 0.78373066 |
| 134 | MP0010234_abnormal_vibrissa_follicle | 0.78131625 |
| 135 | MP0001666_abnormal_nutrient_absorption | 0.76951729 |
| 136 | MP0004019_abnormal_vitamin_homeostasis | 0.76302732 |
| 137 | MP0000751_myopathy | 0.74876495 |
| 138 | MP0004133_heterotaxia | 0.74482607 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.73370096 |
| 140 | MP0005670_abnormal_white_adipose | 0.72583263 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.71785841 |
| 142 | MP0005408_hypopigmentation | 0.71396344 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.71296525 |
| 144 | MP0002254_reproductive_system_inflammat | 0.69813521 |
| 145 | MP0000537_abnormal_urethra_morphology | 0.69351380 |
| 146 | MP0008932_abnormal_embryonic_tissue | 0.69284158 |
| 147 | MP0002896_abnormal_bone_mineralization | 0.68486623 |
| 148 | MP0002925_abnormal_cardiovascular_devel | 0.67604486 |
| 149 | MP0009672_abnormal_birth_weight | 0.67355220 |
| 150 | MP0008961_abnormal_basal_metabolism | 0.66190925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Turricephaly (HP:0000262) | 4.22723516 |
| 2 | Ulnar bowing (HP:0003031) | 4.09565159 |
| 3 | Alopecia of scalp (HP:0002293) | 3.80793291 |
| 4 | Male infertility (HP:0003251) | 3.58867585 |
| 5 | Hypochromic microcytic anemia (HP:0004840) | 3.55485356 |
| 6 | Cerebral aneurysm (HP:0004944) | 3.46256430 |
| 7 | Hyperacusis (HP:0010780) | 3.44375622 |
| 8 | Rib fusion (HP:0000902) | 3.40381688 |
| 9 | Pustule (HP:0200039) | 3.37638339 |
| 10 | Facial hemangioma (HP:0000329) | 3.23433858 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.20637319 |
| 12 | Premature rupture of membranes (HP:0001788) | 3.16071879 |
| 13 | Distal lower limb amyotrophy (HP:0008944) | 3.10495817 |
| 14 | Short humerus (HP:0005792) | 3.08859515 |
| 15 | Annular pancreas (HP:0001734) | 3.05233244 |
| 16 | Coronal craniosynostosis (HP:0004440) | 3.03800468 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.00777090 |
| 18 | Myocardial infarction (HP:0001658) | 2.91786721 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 2.91376851 |
| 20 | Broad face (HP:0000283) | 2.91079168 |
| 21 | Abnormality of the lower motor neuron (HP:0002366) | 2.86526174 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.76051985 |
| 23 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.74938700 |
| 24 | Vaginal fistula (HP:0004320) | 2.70493212 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 2.69920171 |
| 26 | Rectovaginal fistula (HP:0000143) | 2.67389347 |
| 27 | Rectal fistula (HP:0100590) | 2.67389347 |
| 28 | Flat acetabular roof (HP:0003180) | 2.66125839 |
| 29 | Vertebral compression fractures (HP:0002953) | 2.65415398 |
| 30 | Xanthomatosis (HP:0000991) | 2.62442186 |
| 31 | Concave nail (HP:0001598) | 2.60363449 |
| 32 | Poikiloderma (HP:0001029) | 2.60309886 |
| 33 | Muscle fibrillation (HP:0010546) | 2.59967882 |
| 34 | Polycythemia (HP:0001901) | 2.58756068 |
| 35 | Abnormal hemoglobin (HP:0011902) | 2.54781557 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.54106330 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.51152769 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51152769 |
| 39 | Dysmetric saccades (HP:0000641) | 2.48556123 |
| 40 | Intestinal fistula (HP:0100819) | 2.47457490 |
| 41 | Asymmetry of the thorax (HP:0001555) | 2.42574886 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.41810896 |
| 43 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.40522050 |
| 44 | Tongue fasciculations (HP:0001308) | 2.39834719 |
| 45 | Bowed forearm bones (HP:0003956) | 2.39318821 |
| 46 | Bowing of the arm (HP:0006488) | 2.39318821 |
| 47 | Back pain (HP:0003418) | 2.37971063 |
| 48 | Vertebral hypoplasia (HP:0008417) | 2.37842383 |
| 49 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.37842383 |
| 50 | Congenital hip dislocation (HP:0001374) | 2.36978260 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.36368002 |
| 52 | Difficulty climbing stairs (HP:0003551) | 2.35374748 |
| 53 | Orthostatic hypotension (HP:0001278) | 2.34493055 |
| 54 | Hypolipoproteinemia (HP:0010981) | 2.32967157 |
| 55 | Squamous cell carcinoma (HP:0002860) | 2.32824418 |
| 56 | Disproportionate tall stature (HP:0001519) | 2.32014196 |
| 57 | Hyporeflexia of lower limbs (HP:0002600) | 2.31353120 |
| 58 | Increased connective tissue (HP:0009025) | 2.30313490 |
| 59 | Spinal rigidity (HP:0003306) | 2.29503915 |
| 60 | Myoglobinuria (HP:0002913) | 2.23418762 |
| 61 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.22851872 |
| 62 | Large for gestational age (HP:0001520) | 2.21172479 |
| 63 | Abnormality of the astrocytes (HP:0100707) | 2.20158204 |
| 64 | Astrocytoma (HP:0009592) | 2.20158204 |
| 65 | Selective tooth agenesis (HP:0001592) | 2.19234764 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19085707 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19085707 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19085707 |
| 69 | Diaphragmatic weakness (HP:0009113) | 2.18235408 |
| 70 | Abnormality of the fingertips (HP:0001211) | 2.17908490 |
| 71 | Hemorrhage of the eye (HP:0011885) | 2.16902870 |
| 72 | Basal cell carcinoma (HP:0002671) | 2.16615271 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.15802329 |
| 74 | Thin bony cortex (HP:0002753) | 2.15631702 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15369060 |
| 76 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.13300197 |
| 77 | Spastic diplegia (HP:0001264) | 2.12267464 |
| 78 | Hyperammonemia (HP:0001987) | 2.12141432 |
| 79 | Vertebral fusion (HP:0002948) | 2.09771524 |
| 80 | Upper limb amyotrophy (HP:0009129) | 2.09723795 |
| 81 | Distal upper limb amyotrophy (HP:0007149) | 2.09723795 |
| 82 | Abnormality of the thoracic spine (HP:0100711) | 2.09697241 |
| 83 | Pseudobulbar signs (HP:0002200) | 2.09303162 |
| 84 | Type 1 muscle fiber predominance (HP:0003803) | 2.08884720 |
| 85 | Cervical subluxation (HP:0003308) | 2.08298178 |
| 86 | Short nail (HP:0001799) | 2.08295776 |
| 87 | Fragile skin (HP:0001030) | 2.06797784 |
| 88 | Metaphyseal cupping (HP:0003021) | 2.06183222 |
| 89 | Increased mean platelet volume (HP:0011877) | 2.05179324 |
| 90 | Lower limb amyotrophy (HP:0007210) | 2.04718885 |
| 91 | Heterotopia (HP:0002282) | 2.04196323 |
| 92 | Elbow flexion contracture (HP:0002987) | 2.01648215 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 2.01142860 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.99825960 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 1.99825960 |
| 96 | Myopathic facies (HP:0002058) | 1.99254259 |
| 97 | Hand muscle atrophy (HP:0009130) | 1.98528892 |
| 98 | Complement deficiency (HP:0004431) | 1.97590312 |
| 99 | Increased IgM level (HP:0003496) | 1.96884276 |
| 100 | Dislocated radial head (HP:0003083) | 1.96814596 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96751802 |
| 102 | Hypoalphalipoproteinemia (HP:0003233) | 1.96670944 |
| 103 | Dysostosis multiplex (HP:0000943) | 1.95484180 |
| 104 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.95079912 |
| 105 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.95079912 |
| 106 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94963914 |
| 107 | Ketoacidosis (HP:0001993) | 1.94826121 |
| 108 | Shallow orbits (HP:0000586) | 1.93792676 |
| 109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93691296 |
| 110 | Ankyloglossia (HP:0010296) | 1.93415868 |
| 111 | Abnormality of oral frenula (HP:0000190) | 1.92734238 |
| 112 | Blue sclerae (HP:0000592) | 1.92453324 |
| 113 | Hamartoma (HP:0010566) | 1.92347876 |
| 114 | Persistence of primary teeth (HP:0006335) | 1.91801777 |
| 115 | Breast hypoplasia (HP:0003187) | 1.91226431 |
| 116 | Stridor (HP:0010307) | 1.90779155 |
| 117 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90420052 |
| 118 | Ketosis (HP:0001946) | 1.88650298 |
| 119 | Broad alveolar ridges (HP:0000187) | 1.88589379 |
| 120 | Hypochromic anemia (HP:0001931) | 1.88552129 |
| 121 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.87829134 |
| 122 | Natal tooth (HP:0000695) | 1.86180223 |
| 123 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85710045 |
| 124 | Sparse lateral eyebrow (HP:0005338) | 1.85279320 |
| 125 | Long eyelashes (HP:0000527) | 1.84598618 |
| 126 | EMG: neuropathic changes (HP:0003445) | 1.82352231 |
| 127 | Wormian bones (HP:0002645) | 1.81650296 |
| 128 | Long toe (HP:0010511) | 1.81327695 |
| 129 | Increased CSF protein (HP:0002922) | 1.81305647 |
| 130 | Achilles tendon contracture (HP:0001771) | 1.81247455 |
| 131 | Abnormality of complement system (HP:0005339) | 1.80881510 |
| 132 | Spinal cord lesions (HP:0100561) | 1.80874101 |
| 133 | Syringomyelia (HP:0003396) | 1.80874101 |
| 134 | Generalized amyotrophy (HP:0003700) | 1.80550188 |
| 135 | J-shaped sella turcica (HP:0002680) | 1.80509834 |
| 136 | Abnormality of the radial head (HP:0003995) | 1.80154800 |
| 137 | Aneurysm (HP:0002617) | 1.78946895 |
| 138 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.78718253 |
| 139 | Albinism (HP:0001022) | 1.78334035 |
| 140 | Hypoplastic ischia (HP:0003175) | 1.78041574 |
| 141 | Advanced eruption of teeth (HP:0006288) | 1.77649394 |
| 142 | Abnormality of the aortic arch (HP:0012303) | 1.77009657 |
| 143 | Long palpebral fissure (HP:0000637) | 1.76860367 |
| 144 | Short chin (HP:0000331) | 1.76507125 |
| 145 | Insomnia (HP:0100785) | 1.74488921 |
| 146 | Hypotrichosis (HP:0001006) | 1.74395886 |
| 147 | Obstructive sleep apnea (HP:0002870) | 1.74056254 |
| 148 | Spondylolisthesis (HP:0003302) | 1.74033431 |
| 149 | Protrusio acetabuli (HP:0003179) | 1.73907160 |
| 150 | Malnutrition (HP:0004395) | 1.73763445 |
| 151 | Premature skin wrinkling (HP:0100678) | 1.73627560 |
| 152 | Abnormality of the calcaneus (HP:0008364) | 1.73513220 |
| 153 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.73364839 |
| 154 | Mitral regurgitation (HP:0001653) | 1.73001588 |
| 155 | Abnormal platelet volume (HP:0011876) | 1.72991069 |
| 156 | Bladder diverticulum (HP:0000015) | 1.71900544 |
| 157 | Ankle contracture (HP:0006466) | 1.71447447 |
| 158 | Colitis (HP:0002583) | 1.70232822 |
| 159 | Atrophic scars (HP:0001075) | 1.69365521 |
| 160 | Ulnar deviation of the wrist (HP:0003049) | 1.69313930 |
| 161 | Progressive muscle weakness (HP:0003323) | 1.69182534 |
| 162 | Interstitial pulmonary disease (HP:0006530) | 1.68398841 |
| 163 | Mitral valve prolapse (HP:0001634) | 1.67436743 |
| 164 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.66440345 |
| 165 | Aortic aneurysm (HP:0004942) | 1.66318217 |
| 166 | Patellar dislocation (HP:0002999) | 1.65335706 |
| 167 | Genu recurvatum (HP:0002816) | 1.65261169 |
| 168 | Coxa vara (HP:0002812) | 1.65038671 |
| 169 | Thoracic kyphosis (HP:0002942) | 1.64985175 |
| 170 | Dilatation of the ascending aorta (HP:0005111) | 1.64977076 |
| 171 | Abnormal ossification of hand bones (HP:0005921) | 1.64743661 |
| 172 | Trismus (HP:0000211) | 1.64467362 |
| 173 | Abnormality of the acetabulum (HP:0003170) | 1.61365102 |
| 174 | Round ear (HP:0100830) | 1.60075552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 5.47495054 |
| 2 | DDR2 | 3.84826744 |
| 3 | IRAK3 | 3.31061058 |
| 4 | TRIB3 | 3.19823405 |
| 5 | SMG1 | 3.10178985 |
| 6 | MAP3K6 | 3.00282833 |
| 7 | MAP3K11 | 2.83922458 |
| 8 | PRPF4B | 2.59684354 |
| 9 | TYRO3 | 2.57943604 |
| 10 | MAPK15 | 2.50825307 |
| 11 | EEF2K | 2.50611535 |
| 12 | PDGFRA | 2.37622794 |
| 13 | BMX | 2.36191107 |
| 14 | MST1R | 2.31107948 |
| 15 | MAP3K10 | 2.28421484 |
| 16 | CDK12 | 2.06902676 |
| 17 | FGR | 1.93473961 |
| 18 | PKN2 | 1.92106726 |
| 19 | MATK | 1.89826511 |
| 20 | PINK1 | 1.82790742 |
| 21 | CDK6 | 1.71158747 |
| 22 | TRPM7 | 1.70173736 |
| 23 | LATS2 | 1.68941764 |
| 24 | CSK | 1.66576985 |
| 25 | DYRK1B | 1.59704342 |
| 26 | TTN | 1.52822809 |
| 27 | ERN1 | 1.48516615 |
| 28 | NME2 | 1.42861499 |
| 29 | MAPKAPK3 | 1.41331388 |
| 30 | LATS1 | 1.40787350 |
| 31 | PRKD2 | 1.33278993 |
| 32 | MTOR | 1.31796655 |
| 33 | TAOK2 | 1.30299104 |
| 34 | MAP3K13 | 1.28219247 |
| 35 | CDK7 | 1.26594031 |
| 36 | RIPK1 | 1.24504899 |
| 37 | DAPK1 | 1.22299437 |
| 38 | UHMK1 | 1.15780991 |
| 39 | MAPK11 | 1.15069306 |
| 40 | SIK1 | 1.10384229 |
| 41 | KSR2 | 1.07182086 |
| 42 | PIM1 | 1.05511017 |
| 43 | PIM2 | 1.03930897 |
| 44 | NEK1 | 1.02603515 |
| 45 | GSK3A | 1.01406895 |
| 46 | PDPK1 | 1.00919354 |
| 47 | RPS6KB2 | 0.99716601 |
| 48 | STK3 | 0.97799773 |
| 49 | PDK4 | 0.97778780 |
| 50 | PDK3 | 0.97778780 |
| 51 | EPHA2 | 0.96940646 |
| 52 | MAP3K14 | 0.94595794 |
| 53 | NEK2 | 0.93410378 |
| 54 | PTK6 | 0.90953221 |
| 55 | MELK | 0.89474266 |
| 56 | RPS6KL1 | 0.87900308 |
| 57 | RPS6KC1 | 0.87900308 |
| 58 | PHKG1 | 0.87674286 |
| 59 | PHKG2 | 0.87674286 |
| 60 | CDC42BPA | 0.85650721 |
| 61 | ALK | 0.84168413 |
| 62 | PRKD3 | 0.80984506 |
| 63 | TBK1 | 0.79769371 |
| 64 | MAP3K7 | 0.78859723 |
| 65 | ZAP70 | 0.78100706 |
| 66 | FGFR3 | 0.77029200 |
| 67 | MARK2 | 0.76959495 |
| 68 | MAP3K1 | 0.76529649 |
| 69 | PRKAA1 | 0.75437477 |
| 70 | RPS6KA6 | 0.75288980 |
| 71 | PDGFRB | 0.74403520 |
| 72 | RPS6KA1 | 0.72399344 |
| 73 | RPS6KA2 | 0.70309485 |
| 74 | PTK2 | 0.69961447 |
| 75 | CDK4 | 0.69881526 |
| 76 | NEK9 | 0.69098777 |
| 77 | LMTK2 | 0.68415334 |
| 78 | BCKDK | 0.68381939 |
| 79 | MAP2K2 | 0.67907558 |
| 80 | PAK2 | 0.67208548 |
| 81 | STK10 | 0.65422278 |
| 82 | YES1 | 0.65310698 |
| 83 | SCYL2 | 0.63559179 |
| 84 | TAOK1 | 0.60329897 |
| 85 | IRAK4 | 0.59697053 |
| 86 | CHEK2 | 0.57769821 |
| 87 | SIK2 | 0.57694961 |
| 88 | FLT3 | 0.57032098 |
| 89 | TYK2 | 0.56842997 |
| 90 | EGFR | 0.56135822 |
| 91 | NTRK1 | 0.55802594 |
| 92 | RET | 0.55462592 |
| 93 | JAK3 | 0.54554480 |
| 94 | PDK1 | 0.54231940 |
| 95 | FGFR4 | 0.53841228 |
| 96 | IRAK2 | 0.53828604 |
| 97 | MAP3K8 | 0.52955457 |
| 98 | MAPK12 | 0.52702235 |
| 99 | EPHB1 | 0.52206149 |
| 100 | PAK4 | 0.51062836 |
| 101 | PRKAA2 | 0.49197533 |
| 102 | DYRK3 | 0.48377722 |
| 103 | PLK1 | 0.47964551 |
| 104 | CDC7 | 0.47657367 |
| 105 | MAP2K6 | 0.46640958 |
| 106 | MAP2K3 | 0.46483270 |
| 107 | FGFR1 | 0.46476107 |
| 108 | DMPK | 0.45467556 |
| 109 | CAMK1D | 0.45352067 |
| 110 | CHEK1 | 0.44017603 |
| 111 | MAP2K1 | 0.43792599 |
| 112 | MET | 0.43238324 |
| 113 | BRD4 | 0.42667585 |
| 114 | CDK2 | 0.41994165 |
| 115 | MAP3K3 | 0.41468573 |
| 116 | PDK2 | 0.40934564 |
| 117 | HIPK2 | 0.40663593 |
| 118 | ERBB4 | 0.40650538 |
| 119 | PRKG2 | 0.38769815 |
| 120 | TTK | 0.38226312 |
| 121 | SGK3 | 0.37664781 |
| 122 | JAK1 | 0.37626907 |
| 123 | JAK2 | 0.36368871 |
| 124 | CDK9 | 0.36183200 |
| 125 | IRAK1 | 0.35868271 |
| 126 | RPS6KB1 | 0.35274213 |
| 127 | MAPK1 | 0.34827724 |
| 128 | SIK3 | 0.32766300 |
| 129 | MARK3 | 0.32433075 |
| 130 | PRKD1 | 0.32278610 |
| 131 | LRRK2 | 0.32151438 |
| 132 | CAMK1G | 0.31311067 |
| 133 | STK38 | 0.31140336 |
| 134 | MAP3K2 | 0.30863238 |
| 135 | MAPKAPK2 | 0.29127245 |
| 136 | ATR | 0.28299695 |
| 137 | ATM | 0.27150921 |
| 138 | MAP4K1 | 0.25318097 |
| 139 | CHUK | 0.24781818 |
| 140 | AKT2 | 0.24301457 |
| 141 | MAPK3 | 0.23946078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.27416207 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.94483135 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.63901624 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63697216 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.48003556 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.39845902 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.34523713 |
| 8 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.12686392 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.05273483 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.04003552 |
| 11 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.82381591 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 1.80208595 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 1.76961871 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 1.76866232 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.75326938 |
| 16 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.74896479 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74682540 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.72040465 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72024848 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.64969734 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.61447241 |
| 22 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.57005322 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55013383 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.49756867 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42667389 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41075459 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39582810 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39556867 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.39002966 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29379782 |
| 31 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.28829053 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28351097 |
| 33 | Glioma_Homo sapiens_hsa05214 | 1.27883312 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24977184 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.24710517 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24617503 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.23779282 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22559681 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21932990 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18163967 |
| 41 | Prostate cancer_Homo sapiens_hsa05215 | 1.17929998 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17861898 |
| 43 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.15747452 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15354404 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15083835 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 1.14382049 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13325584 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.11638540 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10349352 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.09960658 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.08980258 |
| 52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.06940278 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05328182 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.04978235 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04804476 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04177389 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 1.04072056 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03220197 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.03207614 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 1.02177122 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.00587061 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99802524 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99787540 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99725020 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.99468677 |
| 66 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97429735 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97354066 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96647955 |
| 69 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.95535043 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.95387446 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94824222 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94613696 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92954786 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92663080 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92531222 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92029994 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91721035 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91264765 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.90832560 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90016697 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88904080 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85656055 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84751050 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84065673 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83397016 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81927920 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81888588 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80388734 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78306073 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78187035 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78021611 |
| 92 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77728205 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77651060 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77483770 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76894251 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76849224 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75824880 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75464264 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75126602 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.74854674 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74765968 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74202974 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73443469 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73112369 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72879068 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72846705 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.72347257 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71002865 |
| 109 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.70497536 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69786150 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69486369 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.68314819 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68140147 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67872917 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.66925405 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66879082 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66586155 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65983299 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65461074 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65198298 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64563555 |
| 122 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63479024 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62810380 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62064536 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61624541 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.61396097 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61322401 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.61062800 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60790078 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.59908598 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59652040 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59599144 |
| 133 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59280158 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59239783 |
| 135 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59166509 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.58610758 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58426240 |
| 138 | Peroxisome_Homo sapiens_hsa04146 | 0.57426840 |
| 139 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57348363 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.56603260 |
| 141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54643404 |
| 142 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54296069 |
| 143 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53599485 |
| 144 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52111790 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51541582 |
| 146 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51103000 |
| 147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50507859 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.50245311 |
| 149 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49662804 |
| 150 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49298161 |
| 151 | Legionellosis_Homo sapiens_hsa05134 | 0.48800980 |
| 152 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47611446 |
| 153 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46270789 |
| 154 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45989410 |
| 155 | Cell cycle_Homo sapiens_hsa04110 | 0.45079617 |
| 156 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44666881 |
| 157 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44475020 |
| 158 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43496719 |
| 159 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39645732 |
| 160 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38979431 |

